Chryseobacterium indologenes subcutaneous port-related bacteremia in a liver transplant patient

Transplant Infectious Disease

Volumn 14, Issue 4, 2012, Pages 398-402

  Shah, S ^a   Sarwar, U ^a,b   King, E A ^a   Lat, A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Chryseobacterium indologenes; Levofloxacin; Liver transplantation; Piperacillin tazobactam; Port related bacteremia; Trimethoprim sulfamethoxazole

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; TOBRAMYCIN; TRIMETHOPRIM;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BACTERIAL INFECTION; BACTERIUM CULTURE; BILIARY CIRRHOSIS; BLOOD CULTURE; CASE REPORT; CHRYSEOBACTERIUM INDOLOGENES; CHRYSEOBACTERIUM INDOLOGENES INFECTION; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FLANK PAIN; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FIBROSIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MONOTHERAPY; NONALCOHOLIC FATTY LIVER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CHRYSEOBACTERIUM; FATAL OUTCOME; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; LIVER TRANSPLANTATION; MICROBIAL SENSITIVITY TESTS; TAIWAN;

EID: 84865196627     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00711.x     Document Type: Article

References (21)

1. Hsueh PR, Hsiue TR, Wu JJ, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996; 23: 550-555.
2. Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int J Syst Bacteriol 2004; 44: 827-831.
3. Lu PC, Chan JC. Flavobacterium indologenes keratitis. Ophthalmologica 1997; 211: 98-100.
4. Green BT, Nolan PE. Cellulitis and bacteremia due to Chryseobacterium indologenes. J Infect 2001; 42: 219-220.
5. Kienzle N, Muller M, Pegg S. Chryseobacterium in wound infections. Burns 2001; 27: 179-182.
6. Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ. Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol 2005; 43: 2021-2023.
7. At-Tatari H, Asmar BI, Ang JY. Lumboperitoneal shunt infection due to Chryseobacterium indologenes. Ped Infect Dis J 2007; 26: 657-659.
8. Douvoyiannis M, Kalyoussef S, Philip B, Mayers MM. Chryseobacterium indologenes bacteremia in an infant. Int J Infect Dis 2010; 14: e531-e532.
9. Calderon G, Garcia E, Rojas P, Garcia E, Rosso M, Losada A. Chryseobacterium indologenes infection in a newborn: a case report. J Med Case Reports 2011; 5: 10.
10. Hsueh P, Teng L, Ho S, Hsieh W, Luh K. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 1996; 34: 1908-1913.
11. Lin J, Wang W, Yen C, et al. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect Dis 2003; 35: 882-883.
12. Lin Y, Jeng Y, Lin M, Yu K, Wang F, Liu C. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010; 43: 498-505.
13. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001; 17: 391-393.
14. Akay M, Gunduz E, Gulbas Z. Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant 2006; 37: 435-436.
15. Cascio A, Stassi G, Costa GB, et al. Chryseobacterium indologenes in a diabetic child. J Med Microbiol 2005; 54: 677-680.
16. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hseih WC, Luh KT. Increased incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997; 16: 568-574.
17. Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med 1975; 292: 1099-1102.
18. Siegman-Igra Y, Schwartz D, Soferman G, Konforti M. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med Microbiol Immunol 1987; 176: 103-111.
19. Mermel MA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
20. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY antimicrobial surveillance program (1997-2001). J Clin Microbiol 2004; 42: 445-448.
21. Aber RC, Wenntersten C, Moellering RC Jr. Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother 1978; 14: 483-487.